Q'Apel Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 116

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 3

Q'Apel General Information

Description

Developer of medical devices designed to help physicians overcome their challenges concerning the delivery of successful neurovascular procedures. The company's devices offer access to endovascular treatment of stroke and cerebral aneurysms, providing better trackability in navigating tortuous neurovasculature, enabling medical practitioners to improve both clinical and patient outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4245 Technology Drive
  • Fremont, CA 94538
  • United States
+1 (510)
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 4245 Technology Drive
  • Fremont, CA 94538
  • United States
+1 (510)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Q'Apel Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Secondary Transaction - Private Completed Generating Revenue
7. Later Stage VC 09-May-2024 Completed Generating Revenue
6. Debt - General 01-Aug-2022 Completed Generating Revenue
5. Later Stage VC (Series D) 10-May-2022 Completed Generating Revenue
4. Later Stage VC (Series C) 11-Feb-2021 Completed Generating Revenue
3. Later Stage VC (Series B) 04-Feb-2020 Completed Generating Revenue
2. Early Stage VC (Series A) $15M $15M Completed Startup
1. Accelerator/Incubator Completed Startup
To view Q'Apel’s complete valuation and funding history, request access »

Q'Apel Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D
Series C
Series B 11,378,838 $0.001000 8% $1.06 $1.06 1x $1.06 12.1%
Series A 15,100,000 $0.001000 8% $1 $1 1x $1 16.06%
To view Q'Apel’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Q'Apel Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of medical devices designed to help physicians overcome their challenges concerning the delivery of successful
Therapeutic Devices
Fremont, CA
116 As of 2026

San Antonio, TX
 

Campbell, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Q'Apel Competitors (37)

One of Q'Apel’s 37 competitors is Bluegrass Vascular Technologies, a Formerly VC-backed company based in San Antonio, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bluegrass Vascular Technologies Formerly VC-backed San Antonio, TX
Imperative Care Venture Capital-Backed Campbell, CA
Biotronik Corporate Backed or Acquired Berlin, Germany
Kardium Private Equity-Backed Burnaby, Canada
Cardiac Dimensions Venture Capital-Backed Kirkland, WA
You’re viewing 5 of 37 competitors. Get the full list »

Q'Apel Patents

Q'Apel Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260294440-A1 Laser cut catheters for vascular embolization Pending 25-Mar-2025
WO-2026206829-A1 Laser cut catheters for vascular embolization Pending 25-Mar-2025
WO-2026169568-A1 Flexible tip for aspiration catheters Pending 04-Feb-2025
US-20260115421-A1 Laser-cut tube catheter assembly having variable stiffness Pending 31-Oct-2024
WO-2026096651-A1 Laser-cut tube catheter assembly having variable stiffness Pending 31-Oct-2024 A61M25/0013
To view Q'Apel’s complete patent history, request access »

Q'Apel Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Q'Apel Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
RC Capital (Cincinnati) Growth/Expansion Minority
Soleus Capital Asset Manager Minority
Research Corporation Technologies Venture Capital Minority
To view Q'Apel’s complete investors history, request access »

Q'Apel FAQs

  • When was Q'Apel founded?

    Q'Apel was founded in 2015.

  • Where is Q'Apel headquartered?

    Q'Apel is headquartered in Fremont, CA.

  • What is the size of Q'Apel?

    Q'Apel has 116 total employees.

  • What industry is Q'Apel in?

    Q'Apel’s primary industry is Therapeutic Devices.

  • Is Q'Apel a private or public company?

    Q'Apel is a Private company.

  • What is Q'Apel’s current revenue?

    The current revenue for Q'Apel is .

  • How much funding has Q'Apel raised over time?

    Q'Apel has raised $96.5M.

  • Who are Q'Apel’s investors?

    RC Capital (Cincinnati), Soleus Capital, and Research Corporation Technologies have invested in Q'Apel.

  • Who are Q'Apel’s competitors?

    Bluegrass Vascular Technologies, Imperative Care, Biotronik, Kardium, and Cardiac Dimensions are some of the 37 competitors of Q'Apel.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process